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Endometriosis is a multifactorial disease mostly affecting women of reproductive age and is associated
with chronic pelvic pain and infertility. Even after 300 years, most of the literature claims that patho-
genesis and/or pathophysiology of endometriosis is still elusive. Recurrence of pain and lesion continues
to occur after effective medical or surgical therapies. Once generated within the pelvis due to retrograde
entry of menstrual debris, peritoneal endometriotic lesions time-dependently change their color
appearance resulting from certain biochemical change within lesions. A variable pattern of endometriotic
lesions within the pelvis can be detected by laparoscopy as visible peritoneal endometriosis. It is
generally believed that besides ovarian steroid hormones, the growth of endometriosis can be regulated
by the innate immune system in the pelvic microenvironment by their interaction with endometrial cells
and immune cells. Even with the careful eyes of an expert surgeon, we may sometimes miss detecting
peritoneal lesion within the peritoneal cavity or deep into the peritoneum. In such a case, random
collection of normal peritoneum may carry the possibility to identify some hidden endometriotic lesions
by microscopy and these lesions can be named as occult (invisible) microscopic endometriosis (OME).
Here, we discuss the color appearance of peritoneal lesions and activity of these lesions by analysis of a
panel of activity markers. Finally we discuss our recent ﬁndings on OME, their biological and clinical
signiﬁcance, and try to make a possible link in the origin between visible endometriosis and OME.
Copyright © 2014, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Endometriosis, the presence of functional endometrium outside
the uterine cavity, is a common disease, causing abdominal pain,
dysmenorrhea, dyspareunia, and infertility in about 10% of the
female population.1 Besides metaplastic transformation of
endometrial and peritoneal mesothelial cells, the transplantation,
implantation, and growth of exfoliated menstrual debris on the
peritoneal and ovarian surfaces are the widely accepted mecha-
nisms of endometriosis.2,3 With the elapse of many decades and
abundant publications, the exact physiopathology or pathogenesis
of endometriosis is still debated. The potential role of ovarian ste-
roid hormones in the regeneration of endometrium afterhave no conﬂicts of interest
s and Gynecology, Graduate
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Khan).
for Gynecologic Endoscopy and Minimmenstruation and the growth of endometriosis has been demon-
strated.4 However, as a nonself lesion in the pelvic environment,
the growth or persistence of visible endometriosis can also be
regulated by an innate immune system. Because endometriosis is a
multifactorial disease, we cannot rule out the involvement of
additional factors, such as stress reaction or immunoendocrine
crosstalk in the pelvis of women with visible endometriosis.
Pathogenesis and natural course of peritoneal endometriosis
Common concepts in the pathogenesis of endometriosis
In addition to the transplantation and implantation theory of
Sampson2 and coelomic metaplasia theory of Meyer,5 immuno-
surveillance of reﬂuxed endometrial cells is another attractive
theory for the development of peritoneal endometriosis. The im-
mune tolerance or immune defect theory could explain a deﬁciency
in the rejection of the autologous cells derived from the eutopic
endometrium in the peritoneal cavity after menstrual reﬂux. This
rejection in the clearance of endometrial cells and consequent cellally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
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response in the pelvic cavity.6
According to the retrograde menstruation theory, endometrial
fragments ﬂow back through the patent fallopian tubes, reach the
peritoneal cavity, attach on to the pelvic mesothelium, invade the
peritoneum, and develop into endometriotic lesions.2 Limited in-
formation still exists regarding early endometrialeperitoneal
attachment and invasion in the development of endometriosis.
Role of cell-adhesion molecules in endometriosis
After overcoming a phase of immune tolerance, a key step in the
development of early endometriosis is the ability of endometrial
cells to adhere to mesothelium and invade the extracellular matrix.
These effects are contributed to by a number of intercellular
adhesion molecules and subcellular matrix degrading matrix
metalloproteinases.7 The expressions of these intercellular adhe-
sion molecules and digestive enzymes, such as ﬁbronectin, laminin,
integrins, E-cadherin, and matrix metalloproteinases are already
detected in cells derived from menstrual efﬂuent, endometrium,
peritoneal ﬂuid, peritoneum, and endometriosis.8e11
Role of heme metabolism in endometriosis
A potential implication of hemoglobin in the pathogenesis of
peritoneal endometriosis has been recently reported.12 A simple
hypothesis is that hemoglobin, being released into the peritoneal
cavity after red blood cell lysis, may activate cell adhesion mole-
cules and induce cytokine production, cell proliferation, and the
process of neovascularization. Degradation of hemoglobin yields
biologically active molecules, heme, and its products of oxidative
cleavage by heme oxygeneses such as iron, carbon monoxide,
biliverdin, and bilirubin. Accumulation of heme in the peritoneal
cavity might have a number of deleterious effects including in-
duction of oxidative stress, stimulation of cell adhesion, and cyto-
kine production by macrophages. All these biological events are
ﬁnally involved in the generation of visible peritoneal lesions.
Color changes of visible peritoneal lesions
The lesions of early endometriosis are either transparent or
translucent because they still lack formation of vasculatures around
them. We named these early lesions as transparent/translucent or
nonopaque lesions,13 because these lesions contain either watery,
serous, or mucinous secretion and there is no collection of blood in
the stroma by histology. Once cellular attachment and invasion of
endometrial cells are established, the subsequent growth or
maintenance of endometriotic lesions is maintained by the pro-
motion of mitogenesis and angiogenesis with the continuation of
the menstrual cycle. An orchestrated action of estrogen and other
inﬂammatory or proinﬂammatory mediators contributes to the
growth promoting effect of endometriosis. Overproliferation of
microvessels in the growing endometriotic lesions causes oozing of
blood in the stroma and appears as blood-ﬁlled opaque red lesions
by laparoscope.13 With the progression of time, there is deoxy-
genation from hemoglobin to methemoglobin or hemosiderin
leading to color changes of these opaque red lesions to black or
related lesions. At this stage, collection of blood in the stroma
disappears. Black lesions again changes to white lesions due to the
collection of bilirubin or biliverdin and accumulation of ﬁbrous
tissue. In this stage, the gland gradually becomes smaller and
stroma sometimes disappears due to a deposition of ﬁbrous tissue.
Finally, old lesions disappear and there is a new focus of endome-
triosis due to continuation of menstrual reﬂux. These sequential
events indicate that, once exfoliated, the endometrium enters intothe pelvic cavity, becomes attached to the mesothelial layer, and
then a process of angiogenesis, heme metabolism, and ﬁbrosis
ensue to maintain the natural course of endometriosis (Fig. 1).
Role of macrophages in pelvic inﬂammation and growth of
visible endometriosis
Inﬁltration of macrophages in eutopic and ectopic endometria
As a cell component of the innate immune system, peritoneal
ﬂuid (PF) and eutopic/ectopic endometria derived from women
with endometriosis have been shown to contain higher numbers
of activated macrophages than from control women.14,15 This re-
sults in the secretion of higher concentrations of growth factors,
cytokines, and chemokines in the PF as produced by the stimulated
macrophages in these patients.14 Red peritoneal lesions and their
adjacent peritoneum had the greatest macrophages inﬁltration,
compared with black/white lesions or chocolate cyst walls. These
results indicate that early endometriosis with red peritoneal le-
sions induces a higher inﬂammatory response in the pelvic cavity
than advanced endometriosis.15 The increased tissue inﬂammatory
reaction in the eutopic and ectopic endometria as deﬁned by the
increased tissue inﬁltration of macrophages and production of a
number of macromolecules by these tissues indicate that the
higher tissue activity is related to the growth promotion of endo-
metriotic lesions as well as to pain manifestation of patients.
Higher tissue activities of blood-ﬁlled opaque red lesions indicate
that the growth of endometriosis does not depend on the ﬁbrotic
extension of disease but on the combined effect of different cyto-
kines and growth factors as produced by these tissues.15e17 We
presume that extension of disease could be related to pelvic pain,
but higher tissue activity of endometriosis associated with abun-
dant recruitment and inﬁltration of macrophages could be related
to infertility.
Activity of different visible peritoneal lesions
Higher activity of early endometriosis than advanced endome-
triosis has been reported. However, the pattern of activity in indi-
vidual colored visible endometriotic lesions in the pelvis in
unknown. In a series of studies, we investigated the variation in
activity of different visible peritoneal lesions as proposed by the
current revised American Society of ReproductiveMedicine (ASRM)
classiﬁcation in women with endometriosis. The morphologic ap-
pearances and a panel of tissue activity markers in these visible
lesions are shown in Fig. 2. In addition to tissue inﬁltration of im-
mune cells, microvessel density, production of cytokines/growth
factors, cell proliferation index, and prostaglandin production were
found to be signiﬁcantly higher in opaque red lesions than in either
nonopaque red lesions or in black/white lesions (Fig. 2).13e15,18e20
Opaque red lesions are deﬁned as nontransparent (blood-ﬁlled)
lesions, including polypoid excrescence, blood bled, or ecchymosis,
and nonopaque lesions are deﬁned as translucent (containing se-
rous or mucinous secretion) lesions such as vesicular bleb or
transparent (water containing) lesions such as clear papule (Fig. 2).
Our ﬁndings demonstrate that the different visible peritoneal le-
sions that are included within the same red morphologic group of
the revised-ASRM classiﬁcation have different biological and tissue
activities, and among these lesions, opaque red lesions displayed
the highest activity in women with endometriosis. We presume
that the presence of opaque red lesions in the pelvis may be more
likely to be involved in the occurrence of adhesion, pain manifes-
tation, or in causing a detrimental effect on reproductive outcome.
In search of stimulating agents that may regulate the activity of
these visible lesions, we and others found that direct stimulation of
Fig. 1. Diagrammatic representation of the color changes of visible peritoneal endometriosis in the pelvic cavity. After initial attachment of reﬂuxed endometrial cells with
peritoneal cells producing early endometriotic lesions, the consequent events of mitosis, angiogenesis, metabolic degradation of heme, and appearances of ﬁbrosis result in the
generation of different morphological appearances of peritoneal lesions as shown in this ﬁgure.
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cells (ESCs) with E2 and P resulted in a variable increase in the
secretion of hepatocyte growth factor, vascular endothelial growth
factor, interleukin-6, and tumor necrosis factor-a.17,21,22 It has been
reported that activation with lipopolysaccharide signiﬁcantly
increased the number of macromolecules secreted by either in-
ﬂammatory cells or ESCs.21 We observed that activation of basalFig. 2. Morphological appearance of blood-ﬁlled opaque red lesions (middle column), nono
women with endometriosis as visually detected by laparoscopy. The deﬁnition of nonopaque
described in the text. A panel of activity markers indicates that activity of opaque red lesioperitoneal macrophages with lipopolysaccharide further enhanced
the response of these cells to ovarian steroids.21 This indicates that
in addition to primary and secondary inﬂammatory mediators,
ovarian steroids equally produce a pelvic inﬂammatory reaction
mediated by macrophages.17 An inﬂammatory response and
ovarian steroid hormones may function either alone or in combi-
nation to regulate the production of a variety of macromolecules bypaque red lesions (left column), and black/white lesions (right column) in the pelvis of
, opaque, and black (blue berry spot)/white (yellow brown) visible peritoneal lesions is
ns is higher than in nonopaque red lesions or in black/white lesions.
Fig. 3. Three microscopically detected patterns of occult microscopic endometriosis in visually normal peritoneum. Pattern I shows presence of typical gland/stroma; pattern II
shows reactive hyperplastic change of endometrioid epithelial cells with surrounding stroma; and pattern III shows single-layered epithelium-lined cystic lesions with surrounding
stromal cells (all in hematoxylin and eosin stain, upper column). The identiﬁcation of glandular epithelial cells, stromal cells and peritoneal mesothelial cells was conﬁrmed by
immunoreaction to Ber-EP4, CD10, and calretinin, respectively and are shown against each hematoxylin and eosin stained slide. Flat mesothelial cells derived from normal
peritoneum and mesothelioma cells as a positive control (inset) immunoreactive to calretinin are shown in the right panel. The immunoreactions to nonimmune mouse immu-
noglobulin G as a negative control are shown in the right panel. Magniﬁcation of slides: 200.
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environment in women with endometriosis may be contributed to
by an orchestration of immune cells, visible endometrial lesions, as
well as by endometria.
Occult microscopic endometriosis
The detection and visible diagnosis of peritoneal endometriosis
is usually performed by laparoscopy, a gold standard modality, and
is microscopically conﬁrmed by histopathology. Even with the
careful eyes of expert surgeons, there is an obvious chance to miss
or overlook hidden (occult) lesions in visually normal peritoneum.
Therefore, immense interest could arise to randomly collect visu-
ally normal peritoneum from a different anatomical location in the
pelvis and to investigate the nature of these visually undetectable
lesions of endometriosis. The concept of microscopic endometriosis
(so-called invisible microscopic endometriosis) in visually normal
peritoneum was ﬁrst reported by Murphy et al in 198623 and sub-
sequently conﬁrmed with an incidence rate of 6e13%.24,25 With the
elapse of more than 1 decade, further information on invisible or
occult microscopic endometriosis (OME) is lacking.
We histologically examined all biopsy specimens derived from
visually normal peritoneum of women with and without endo-
metriosis to detect the possible occurrence of OME. The designation
of visually normal peritoneum was based on a modiﬁed criteria by
Redwine.26 We did not perform contact laparoscopy; instead, our
laparoscope tip was 3e4 cm away from the surface of the perito-
neum. The question still remains: if hidden endometriosis lesions
could be detected in normal peritoneum, are these invisible lesions
really inactive as proposed in a previous report27 or do they truly
retain some biological activity? If tissue activity of OME is there,
this could be a clinically important issue. To address this question,we investigated the expression patterns of some tissue activity
markers including ovarian steroid receptors and cell proliferation
markers in histologically conﬁrmed OME lesions.
Pattern of occult microscopic endometriosis in normal peritoneum
After careful observation and analysis, we collected 227 visually
normal peritoneal samples from 151 women with visible endo-
metriosis and 78 samples from 62 women without any visible
peritoneal lesions (control). We detected three patterns of OME: (1)
presence of typical gland/stroma, (2) reactive hyperplastic change
of endometrioid like epithelium with surrounding stroma, and (3)
single-layered mesothelium or epithelium-lined cystic lesions with
a surrounding rim of stromal cells. All these OME lesions were
conﬁrmed by their immunoreactivity to Ber-EP4 (marker of gland
epithelium), CD10 (marker of stroma), and nonreactivity to calre-
tinin (marker of mesothelial cells; Fig. 3). All these OME lesions
were detected at a depth of 10e80 mm from the surface of the
peritoneum.
We could detect variable patterns of OME in the normal peri-
toneum derived from 23 women with endometriosis (biopsy
samples, n ¼ 27) and four control women (biopsy samples, n ¼ 4)
without visible endometriosis. The detection rate of OME was as
follows: for endometriosis, 15.2% (23/151) and 11.8% (27/227); for
control women, 6.4% (4/62) and 5.1% (4/78) by the number of pa-
tients and number of collected samples, respectively. A higher
tendency in the incidence of OMEwas found inwomenwith visible
endometriosis than in control women (p ¼ 0.06 by patient number
and p ¼ 0.07 by sample number, c2 test).28
A predominance of OME occurrence was observed in the pouch
of Douglas and uterovesicle space than in other anatomical sites in
the pelvis. A dominant presence of r-ASRM Stage I-II endometriosis,
Fig. 4. Some hypothetical proposals that may be linked to the possible origin of visible
endometriosis as well as occult microscopic endometriosis (OME). Sampson's theory2
can be linked directly or indirectly to the origin of both visible and occult endome-
triosis as mentioned in the text. After initial attachment of menstrual debris to the
peritoneum, a sequence of epithelialemesenchymal transition (EMT) or mesen-
chymaleepithelial transition (MET) may be involved in the generation of OME. He-
matogenous or lymphogenous dissemination of shedding endometrial cells during
menstruation could be another approach in the development of these two entities of
peritoneal endometriosis. In addition to possible origin from progenitor cells/stem
cells, cellular change of ﬂat mesothelium to cuboidal or columnar cells (metaplasia
theory) or activated cells derived from residing celomic epithelium (Müllerian rests)
within peritoneum (Mülleriosis, induction theory) in response to pelvic inﬂammation
could be linked to the origin of OME as well as visible endometriosis.
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women with visible endometriosis harboring OME in their
peritoneum.28
Estrogen receptor/progesterone receptor/Ki-67 expression in OME
lesions
A variable estrogen receptor and progesterone receptor immu-
noexpressions were observed in all OME lesions detected inwomen
with visible endometriosis and control women. Although insignif-
icant, the immunoreaction of progesterone receptor as measured
by quantitativeehistogram score appeared to be higher in all pat-
terns of OME lesions compared to estrogen receptor expression.We
could also detect a variable amount of aromatase cytochrome P450
expression in both visible and OME lesions.28 In our previous study,
we found a small amount of estrogen and progesterone in the PF of
women with endometriosis.18
A stronger immunoreaction of Ki-67 (cell proliferation marker)
was found in pattern I/II OME lesions than in pattern III OME lesions
detected in women with visible endometriosis. Weak Ki-67
expression was found in pattern I/III OME lesions diagnosed in
control women. Ki-67 index (mean percentage of Ki-67-positive
nuclei among total cells) was signiﬁcantly higher in pattern I/II
OME lesions than in pattern III OME lesions found in women with
visible endometriosis.28
We do not accept the argument by Donnez and Langendonckt27
that OME lesions are quiescent and they are nonactive or inactive
and that these lesions are clinically irrelevant. Our ﬁndings indicate
that a proportion of occult peritoneal lesions are indeed biologically
active and a substantial amount of estrogen and different inﬂam-
matory mediators in the pelvis might be involved in the growth
promotion of OME lesions even though they are undetectable by
naked eyes. With the inﬂuence of both systemic and local estrogen,
these OME lesions, even if minute in size, may time-dependently
increase in size to be recognized by histology. This could be
responsible for the subsequent recurrence/occurrence of endo-
metriotic lesions or persistence/recurrence of pain symptoms even
after successful excision or ablation of visible peritoneal lesions by
laparoscopy. Further studies in humans or primates are necessary
to establish this possibility. From a logical point of view, it is difﬁ-
cult to trace these growing lesions on the peritoneal surface by
repeated surgical procedures in humans.
Origin of OME lesions
The most alarming questions may arise now: “How can we
decide the origin of OME lesions?” or “Is Sampson's theory enough
to explain OME lesions?” There are no deﬁnite answers at present,
but we argue that we can link each and every theory supporting the
origin of visible endometriosis29 to the pathogenesis of OME lesions
as shown in Fig. 4.
If Sampson's2 theory does not directly support the origin of OME
lesions, it can be indirectly explained by lymphatic or hematoge-
nous spread of menstrual debris and subsequent localization deep
into peritoneum. In fact, variable immunoexpression of a marker of
lymphatic vessels (D2-40) and von Willebrand factor was found in
lymphatic cells and microvessels of all examined biopsies derived
fromwomenwith visible endometriosis and in control women. But
we could not localize any OME lesion within lymphatic or vascular
channels in any of the biopsy samples examined.28 A recent study
based on scanning electron microscopy found that endometrial
cells extend well beyond visible implants of endometriosis and
appear to disrupt the structural integrity of the underlying meso-
thelium.30 This ﬁnding may somehow link Sampson's theory with
the origin of OME lesions.We cannot exclude the possibility of a genetic factor or meta-
plastic transformation of peritoneal mesothelial cells (metaplasia
theory) in response to estrogen, inﬂammation, or environmental
factors. Despite the possible origin of OME as a result of epi-
thelialemesenchymal transition/mesenchymaleepithelial transi-
tion or from progenitor cells/stem cells,31,32 activation of cells
derived from coelomic epithelium (Mülleriosis, induction theory)
within the peritoneum may be another possible mechanism to
explain the origin of OME.33
In addition to recognizing Müllerian tissue and epithelial
ovarian cancer cells, CA125/MUC16 can be used as a marker to
identify cells derived from coelomic epithelium (embryonic origin)
and its derivatives.34 With this concept in mind, we extended our
experiment to immunolocalize cells of embryonic origin by
immunoreaction to CA125/MUC16 in OME lesions. As a marker of
coelomic epithelial cells, we found immunoreaction of CA125/
MUC16 in visible endometriosis and in all patterns of OME le-
sions.28 The immunoreaction of CA125/MUC16 was also found to
normal peritoneal mesothelium. These ﬁndings may support the
notion that cells of visible and occult endometriosis could be of
embryonic origin (Mülleriosis). We speculate that the trans-
formation of peritoneal mesothelial cells (metaplasia theory) or
time-dependent activation of coelomic epithelium (induction the-
ory arising from Müllerian rests) within peritoneum may explain
the origin of OME lesions in our study. Further studies are needed to
strengthen our current ﬁndings.
Summary and perspective
Visible endometriosis and OME are two different entities of
peritoneal endometriosis. Although visible lesions are detected by
visible inspection on the surface of the peritoneum by laparoscopy,
OME lesions cannot be detected by visual inspection, but rather can
be diagnosed under the microscope in randomly collected visually
normal peritoneum. We have re-established a more than decade
old concept of so-called invisible endometriosis (OME here). We
demonstrated that the occurrence of OME in visually normal
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metriosis than in control women. A variable amount of tissue ac-
tivity persists in different visible peritoneal lesions. The possible
factors that can be linked to the pathogenesis of visible endome-
triosis, may also equally contribute to the origin of OME.
The classical histological diagnosis of endometriosis differs in
point of views between gynecologists and histopathologists. All
clinical gynecologists accept diagnosis of endometriosis based on
the ﬁndings of typical endometrial glands with peripheral rim of
stromal cells, but the majority of histopathologists disagree with
this deﬁnition and deﬁne endometriosis just by the presence of
stromal cells around cells of coelomic epithelium such as gland
cells, endometrioid epithelial cells, or mesothelial cells. Because
this is a histopathology-based study, we deﬁned endometriosis
according to the opinion of an expert pathologist at our University
(M.N.). From our ﬁndings we can at least argue that OME lesions are
indeed active and retain variable growth potentiality in response to
cyclic estrogen and/or various inﬂammatory mediators in the
pelvis.
When there is persistence/recurrence of pain or development of
overt endometriosis even after successful surgical ablation of
visible endometriosis in the pelvis, we should keep its possible link
with OME in mind, although emerging evidence supporting this
phenomenon is still lacking. Because active peritoneal lesions in
women with early endometriosis were mostly associated with the
occurrence of OME in this study, we propose that wide area surgical
excision or ablation of active visible lesions can be more effective in
preventing or reducing the generation of OME lesions rather than
to undertake any invasive intervention such as total pelvic perito-
neal excision. Further studies are still needed to address this
proposal.
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